The FDA is requiring new warnings on Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP-1s about a potential increase in the risk of a rare eye condition that can cause sudden vision loss.
Open original sourceComments stay attached to this story.
Start a connected post from this article without changing the original story.
A new study suggests that replacing even 20% of dairy intake with plant-based alternatives could increase the risk of inadequate iodin…
Vitamin K shot refusal rates among U.S. newborns more than doubled from 3.1% in 2017 to 6.8% in 2025, while cases of vitamin K deficie…
Over a third of infants with suspected peanut allergies did not react to peanut in an oral food challenge, according to a new study. T…
Black people are strikingly aligned with MAHA, even if they don’t officially subscribe to the movement, expert writes.
High food costs and cuts to assistance make nutritious food increasingly risky for parents to buy.
Relying on BMI to diagnose obesity has its limitations. Experts are examining what the impact of one proposed alternative would be.
Creators building their communities through the SpiderTaz Creator Program.
No comments yet.